Ethos Cannabis is partnering with Thomas Jefferson University to host the Pennsylvania Medical Marijuana Education & Research Summit on Friday, September 5, 2025, at Jefferson's Alumni Hall Atrium from 8:00 am to 3:30 pm ET.
With more than 425,000 registered medical marijuana patients and a growing push toward adult-use legalization, Pennsylvania is at a pivotal moment in its cannabis evolution. Positioned as one of the nation's most established medical-only cannabis markets, the Commonwealth now faces a unique opportunity to set the national standard for evidence-based cannabis policy, clinical research, and patient-first care.
The summit will feature expert panels, educational sessions, and networking focused on the future of cannabis science and patient care. The summit will feature a keynote talk from Deputy Meghna Patel, Deputy Secretary of Policy and Planning at the Office of Governor Josh Shapiro, and talks from the Philadelphia Department of Public Health, Cannabis Control Commission, Drexel University, Thomas Jefferson University, Ethos Cannabis, and more.
One of the key discussions, "Keystone Shift – The Opioid Epidemic and the Role of Cannabis in Harm Reduction," will be moderated by Allison Herens of the Philadelphia Department of Public Health. The panelists for this discussion include Steve Hoffman, the former Chair of the Massachusetts Cannabis Control Commission; Dr. Stephen Lankenau, a Professor and the Director of the Medical Cannabis Research Center at Drexel University; and Dr. Bill McLay, the Lead Medical Professional at Ethos Cannabis.
The second discussion is "Potency, Policy, and Public Health – Rethinking THC Limits," moderated by Greg Garber, a PharmD from Thomas Jefferson University. The panelists for this session include Emily Hajjar, PharmD, from the Jefferson College of Pharmacy; Patrick LaRose, the Vice President of Production at Ethos Cannabis; and Mallory Paul, the Vice President of Commercial Development at ACT Labs.
"The future of cannabis is grounded in education, science, and service," said Gibran Washington, CEO of Ethos Cannabis. "This summit is a reflection of our mission to advance patient care and policy by bringing the right people to the table—from public health officials and researchers to operators and educators. Pennsylvania is poised to lead, and we're proud to be part of that work."
"As a physician and researcher, I've seen firsthand how important it is to have evidence-based conversations around cannabis," said Dr. Brooke Worster, Chief Medical Officer at Ethos Cannabis and Medical Director at Thomas Jefferson University. "Our goal is to foster real-world understanding of how cannabis can complement traditional care, especially as we face overlapping public health crises like opioid misuse and chronic pain."
To register or stream panels virtually, please visit the event page here.
For more information:
Ethos Cannabis
www.ethoscannabis.com
